PREVIOUS CASE-CONTROL STUDIES have shown no evidence or, at most, little evidence of an increased risk of breast cancer in users of oral contraceptives (Arthes et al., 1971; fHenderson et al., 1974; Fasal & Paffenbarger, 1975 : Paffenbarger et al., 1977 Sartwell et al., 1977; Lees et al., 1978; Brinton et al., 1979; Paffenbarger et al., 1979; Vessey et al., 1979) . However, large-scale use of these compounds did not begin until the mid-1960s, and it is possible that these studies did not find much evidence of an association because long-term use of oral contraceptives was still uincommon, and there may be a long latent period between first exposure and disease. Furthermore, breast-cancer risk rises dramatically with age, so that, even if studies are restricted to premenopausal women, most cases will be in their 40s. These previous studies have thus, in fact, measured risk associated with oral contraceptive use in the middle and later years of reproductive life, mostly after the first full-term pregnancy.
Age at first full-term pregnancy is, however, a critical risk factor for breast cancer (MacMahon et al., 1973) (Mack, 1977 Each patient was also requested to provide the name of a school friend with whom she had maintained contact; to avoid bias we used a selection algorithm which began with high-school friends. Friend controls were found and interviewed for 119 cases. We obtained one or both controls for all cases.
All interviews were conducted by telephone by I.R. Information thus obtained included reproductive, menstrual, contraceptive, and gynaecological history, hormone and other drug use, and family history of cancer, up to the date of diagnosis of breast cancer. Each control was given a "pseudodiagnosis" date which was the date on which she would have been the exact age her matched patient was at diagnosis of breast cancer. The diagnosis/ pseudodiagnosis date is referred to below as the "relevant date". The use of any drugs for the first time within 6 months of the relevant date was ignored.
Multivariate logistic regression methods for individually matched case-control studies were used for statistical analysis (Breslow et at., Holford et al., 1978; Pike et al., 1980) .
RESULTS
No significant differences were found between our analyses using either only the neighbourhood controls or only the friend controls, so we have considered both controls simultaneously in the analysis presented here. 65% of the controls had birth dates within 2 years of their matched control, and on average they were born 9 months earlier.
The relative risk (RR) for breast cancer was statistically significantly increased by a history of the disease in mother or sister (1st-degree relative), by a history of benign breast disease, by earlier menarche, and by long-term use of oral contraceptives (Table I) . RR was decreased by having had a full-term (28 weeks or longer) pregnancy, but the result was not statistically significant, and there was no clear trend with the age at first full-term pregnancy (FFTP).
RR for oral contraceptive (OC) use was roughly doubled if we only considered use before FFTP (Table II) 1-84 were based on very few cases: in the first 0°°s tudy there were 17 cases and no data io OC use before were given on duration of OC; in the second study there were 16 cases, only 4 of whom had used OC for more than 2 rncer in relation years. Paffenbarger et al. (1979) Vessey et al. (1979) found that breasteeks.
cancer patients who had used the pill during the year before diagnosis had a ving a first-better prognosis than other breast-cancer their FFTP patients. As we only studied living 15, Table IV) . patients, such an effect could erroneously the abortion suggest that OC was associated with ,d: 11/24 such breast-cancer risk. We investigated this aced, and 8/17 possible bias by dividing the cases into ver somewhat strata depending on the length of time en who subse-from diagnosis to interview, but found no he other risk evidence that this influenced the OC ppeared inde-finding. ,ted with such Multivariate analysis of our data sug-3 lasting more gests that the risk factors of mother or n abortion did sister with breast cancer, and early risk of breast menarche, both act in such a way that fter the FFTP. the joint risk associated with these conditions and OC is the product of the risks associated with each. This implies that the added risk of such OC use by these high study of Los risk women is more than for other women. less than 33 The results of OC use and benign breast evidence that disease (BBD) (see Table III ) are a little ceptives before difficult to interpret, since OC is known to y may carry a decrease the frequency of BBD, so that of breast can-BBD in a woman who has used OC is not not explained strictly comparable to the disease in a known breast-woman who has not. Nevertheless, conquestion of sideration of when the BBD was diagk extends to nosed allows one to draw a number of conclusions. Firstly, the development of BBD while actually using OC or after prolonged use of OC carries with it a very high risk of subsequent breast cancer. Secondly, OC needs to be used with caution in all women with a history of BBD. The amount of data we have on this latter point is very small, but it agrees with the studies of Lees et al. (1978) and Brinton et al. (1979) both of which suggest that OC at any time in women with BBD may increase the risk of breast cancer. The results of the two studies of Paffenbarger and his colleagues (1977, 1979) contradict one another on this point.
Our finding that a first-trimester abortion, whether spontaneous or induced, before first full-term pregnancy appears to cause a substantial increase in risk of subsequent breast cancer has not to our knowledge been reported before. MacMahon and his colleagues in their international case-control studies did find abortion to be associated with a slight increase in breast-cancer risk, but they did not specifically study abortions before FFTIP nor did they distinguish firsttrimester from later abortions (Valaoras et al., 1969; Yuasa & MacMahon, 1970; Lin et al., 1971; MacMahon et al., 1973) .
Our finding makes biological sense if one considers breast tissue as merely proliferating in early first pregnancy; the protective effect of first full-term pregnancy is then brought about by a combination of cell differentiation and possibly permanently altered hormone levels Cole et al., 1976) . If this finding is substantiated and if it continues to be a strong risk factor into middle age, it will be of major importance, since abortion before FFTP has recently become increasingly common in many countries.
